European directive has doubled cost of running trials in UK
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39055.352905.DB (Published 07 December 2006) Cite this as: BMJ 2006;333:1190
- Roger Dobson
- 1Abergavenny
New European regulations have delayed non-commercial trials in the United Kingdom relating to cancer and doubled the cost of running them, a new study says.
The European Union's clinical trials directive has stopped most clinical trials units in the UK from running trials in international centres, and three out of eight units have been unable to open or take part in a trial because it would be too difficult or expensive for them, says the study, which was published online ahead of print publication on 21 November in the European Journal of Cancer (www.sciencedirect.com, doi: 10.1016/j.ejca.2006.09.016).
“Rather than …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (plus VAT)
You can download a PDF version for your personal record.